148 related articles for article (PubMed ID: 32770634)
1. Association of a Serum Protein Signature With Rheumatoid Arthritis Development.
O'Neil LJ; Spicer V; Smolik I; Meng X; Goel RR; Anaparti V; Wilkins J; El-Gabalawy HS
Arthritis Rheumatol; 2021 Jan; 73(1):78-88. PubMed ID: 32770634
[TBL] [Abstract][Full Text] [Related]
2. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
[TBL] [Abstract][Full Text] [Related]
3. Expansion of Alternative Autoantibodies Does Not Follow the Evolution of Anti-Citrullinated Protein Antibodies in Preclinical Rheumatoid Arthritis: An Analysis in At-Risk First Degree Relatives.
Anaparti V; Smolik I; Meng X; O'Neil L; Jantz MA; Fritzler MJ; El-Gabalawy H
Arthritis Rheumatol; 2021 May; 73(5):740-749. PubMed ID: 33538122
[TBL] [Abstract][Full Text] [Related]
4. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
[TBL] [Abstract][Full Text] [Related]
5. TLR1/2 and 5 induce elevated cytokine levels from rheumatoid arthritis monocytes independent of ACPA or RF autoantibody status.
Thwaites RS; Unterberger S; Chamberlain G; Walker-Bone K; Davies KA; Sacre S
Rheumatology (Oxford); 2020 Nov; 59(11):3533-3539. PubMed ID: 32594150
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis.
Anaparti V; Meng X; Hemshekhar M; Smolik I; Mookherjee N; El-Gabalawy H
PLoS One; 2019; 14(9):e0219109. PubMed ID: 31557191
[TBL] [Abstract][Full Text] [Related]
7. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.
Ioan-Facsinay A; Willemze A; Robinson DB; Peschken CA; Markland J; van der Woude D; Elias B; Ménard HA; Newkirk M; Fritzler MJ; Toes RE; Huizinga TW; El-Gabalawy HS
Arthritis Rheum; 2008 Oct; 58(10):3000-8. PubMed ID: 18821680
[TBL] [Abstract][Full Text] [Related]
8. Serum proteomic networks associate with pre-clinical rheumatoid arthritis autoantibodies and longitudinal outcomes.
O'Neil LJ; Meng X; Mcfadyen C; Fritzler MJ; El-Gabalawy HS
Front Immunol; 2022; 13():958145. PubMed ID: 36159862
[TBL] [Abstract][Full Text] [Related]
9. Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.
El-Gabalawy HS; Robinson DB; Smolik I; Hart D; Elias B; Wong K; Peschken CA; Hitchon CA; Li X; Bernstein CN; Newkirk MM; Fritzler MJ
Arthritis Rheum; 2012 Jun; 64(6):1720-9. PubMed ID: 22354869
[TBL] [Abstract][Full Text] [Related]
10. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
[TBL] [Abstract][Full Text] [Related]
11. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
[TBL] [Abstract][Full Text] [Related]
12. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
[TBL] [Abstract][Full Text] [Related]
13. Subclinical inflammation in the preclinical phase of rheumatoid arthritis might contribute to articular joint damage.
Gomez-Moreno M; Ramos-González EJ; Castañeda-Delgado JE; Castillo-Ortiz JD; Ramos-Remus C; Zapata-Zúñiga M; Méndez JA; Monsiváis-Urenda A; Portales-Pérez DP; Enciso-Moreno JA; Bastián Y
Hum Immunol; 2020 Dec; 81(12):726-731. PubMed ID: 32690328
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Study of the Development of Inflammatory Arthritis in the Family Members of Indigenous North American People With Rheumatoid Arthritis.
Tanner S; Dufault B; Smolik I; Meng X; Anaparti V; Hitchon C; Robinson DB; Robinson W; Sokolove J; Lahey L; Ferucci ED; El-Gabalawy H
Arthritis Rheumatol; 2019 Sep; 71(9):1494-1503. PubMed ID: 30861615
[TBL] [Abstract][Full Text] [Related]
15. The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study.
Murata K; Hashimoto M; Yamamoto W; Son Y; Amuro H; Nagai K; Takeuchi T; Katayama M; Maeda Y; Ebina K; Hara R; Jinno S; Onishi A; Murakami K; Tanaka M; Ito H; Mimori T; Matsuda S
Rheumatol Int; 2020 Feb; 40(2):217-225. PubMed ID: 31620864
[TBL] [Abstract][Full Text] [Related]
16. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
Hitchon CA; Chandad F; Ferucci ED; Willemze A; Ioan-Facsinay A; van der Woude D; Markland J; Robinson D; Elias B; Newkirk M; Toes RM; Huizinga TW; El-Gabalawy HS
J Rheumatol; 2010 Jun; 37(6):1105-12. PubMed ID: 20436074
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis.
O'Neil LJ; Hu P; Liu Q; Islam MM; Spicer V; Rech J; Hueber A; Anaparti V; Smolik I; El-Gabalawy HS; Schett G; Wilkins JA
Front Immunol; 2021; 12():729681. PubMed ID: 34867950
[TBL] [Abstract][Full Text] [Related]
19. Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis.
Ouboussad L; Hunt L; Hensor EMA; Nam JL; Barnes NA; Emery P; McDermott MF; Buch MH
Arthritis Res Ther; 2017 Dec; 19(1):288. PubMed ID: 29273071
[TBL] [Abstract][Full Text] [Related]
20. Complement and its environmental determinants in the progression of human rheumatoid arthritis.
Bemis EA; Norris JM; Seifert J; Frazer-Abel A; Okamoto Y; Feser ML; Demoruelle MK; Deane KD; Banda NK; Holers VM
Mol Immunol; 2019 Aug; 112():256-265. PubMed ID: 31207549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
